These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 9394163

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Suppression and recovery of the hypothalamic function after high-dose corticosteroid treatment in preterm infants.
    Ng PC, Lam CW, Lee CH, Chan IH, Wong SP, Fok TF.
    Neonatology; 2008; 94(3):170-5. PubMed ID: 18612214
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Spontaneous growth hormone secretion and IGF1:IGFBP3 molar ratios in children born small for gestational age (SGA).
    Völkl TM, Schwöbel K, Simm D, Beier C, Rohrer TR, Dörr HG.
    Growth Horm IGF Res; 2004 Dec; 14(6):455-61. PubMed ID: 15519254
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effect of enteral IGF-1 supplementation on feeding tolerance, growth, and gut permeability in enterally fed premature neonates.
    Corpeleijn WE, van Vliet I, de Gast-Bakker DA, van der Schoor SR, Alles MS, Hoijer M, Tibboel D, van Goudoever JB.
    J Pediatr Gastroenterol Nutr; 2008 Feb; 46(2):184-90. PubMed ID: 18223378
    [Abstract] [Full Text] [Related]

  • 30. The endocrine consequences for very low birth weight premature infants.
    Cutfield WS, Regan FA, Jackson WE, Jefferies CA, Robinson EM, Harris M, Hofman PL.
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S130-5. PubMed ID: 15135795
    [Abstract] [Full Text] [Related]

  • 31. [Effect of corticosteroids on lung function and the clinical course of bronchopulmonary dysplasia in premature infants with a birth weight below 1,500 g].
    Hanssler L, Zhou C, Roll C, Wiesemann HG.
    Klin Padiatr; 1994 Jun; 206(5):372-6. PubMed ID: 7799612
    [Abstract] [Full Text] [Related]

  • 32. Growth restriction in dexamethasone-treated preterm infants may be mediated by reduced IGF-I and IGFBP-3 plasma concentrations.
    Bloomfield FH, Knight DB, Breier BH, Harding JE.
    Clin Endocrinol (Oxf); 2001 Feb; 54(2):235-42. PubMed ID: 11207639
    [Abstract] [Full Text] [Related]

  • 33. Extremely low-dose dexamethasone to facilitate extubation in mechanically ventilated preterm babies.
    Tanney K, Davis J, Halliday HL, Sweet DG.
    Neonatology; 2011 Feb; 100(3):285-9. PubMed ID: 21701221
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Dexamethasone does not affect vasopressin release in bronchopulmonary dysplasia.
    Zanardo V, Golin R, Chiozza ML, Faggian D.
    Pediatr Nephrol; 2000 Dec; 15(3-4):241-4. PubMed ID: 11149118
    [Abstract] [Full Text] [Related]

  • 38. Effects of aggressive parenteral nutrition on growth and clinical outcome in preterm infants.
    Can E, Bülbül A, Uslu S, Cömert S, Bolat F, Nuhoğlu A.
    Pediatr Int; 2012 Dec; 54(6):869-74. PubMed ID: 22882288
    [Abstract] [Full Text] [Related]

  • 39. [Effect of dexamethasone and spironolactone therapy in calcium and phosphate homeostasis in premature infants with a birth weight under 1,500 g].
    Sonntag J, Gaude M.
    Klin Padiatr; 1998 Dec; 210(5):354-7. PubMed ID: 9782479
    [Abstract] [Full Text] [Related]

  • 40. Growth and neurodevelopment in extremely low-birth-weight neonates exposed to postnatal steroid therapy.
    LeFlore JL, Engle WD.
    Am J Perinatol; 2011 Sep; 28(8):635-42. PubMed ID: 21512966
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.